Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck

被引:0
|
作者
Anna-Maria A. De Costa
Corinne A. Schuyler
David D. Walker
M. Rita I. Young
机构
[1] Ralph H. Johnson Veterans Affairs Medical Center,Research Service (151)
[2] Medical University of South Carolina,Department of Otolaryngology, Head and Neck Surgery
[3] Medical University of South Carolina,Department of Medicine
来源
Cancer Immunology, Immunotherapy | 2012年 / 61卷
关键词
HNSCC; Premalignant; Immunoediting; Th1/Tc1 cells; Th17 cells;
D O I
暂无
中图分类号
学科分类号
摘要
While studies have indicated that squamous cell carcinoma of the head and neck (HNSCC) is associated with immune suppression, these studies did not analyze the immune response at the dysplastic stage. The present study utilized a mouse model of 4-nitroquinoline 1-oxide-induced oral carcinogenesis to examine the alterations in immune phenotype at the premalignant and malignant stages of HNSCC. Cervical lymph nodes of HNSCC-bearing mice were found to contain a greater number of cells, including a greater number of conventional (Tconv) and regulatory (Treg) T cells, compared to cervical lymph nodes of control and premalignant lesion-bearing mice, though the Tconv cells appear to be less proliferative and the Treg cells appear to be less suppressive at the HNSCC stage. Premalignant lesion-bearing mouse lymph nodes consist of a greater percentage of Tconv cells expressing markers for activation, memory, and exhaustion compared to both control and HNSCC-bearing mice. Also, lymph nodes’ cells from both premalignant lesion-bearing and HNSCC-bearing mice include increased levels of Th1, Tc1, and Th17 cells, with no differences in levels of Th2 cells, compared to control mice. The data show that while there is the expected increase in immunosuppressive Tregs in lymph nodes when HNSCC is present, there is also an unexpected increase in immune populations usually associated with a beneficial antitumor response, including Tconv cells and Th1 and Tc1 cells. In addition, the results demonstrate that the premalignant stage of HNSCC development is associated with a robust immune response involving an increase in inflammatory Th1, Tc1, and Th17 cells.
引用
收藏
页码:927 / 939
页数:12
相关论文
共 50 条
  • [21] Potential biomarkers for head and neck squamous cell carcinoma
    Brown, JJ
    Xu, H
    Nishitani, J
    Mohammed, H
    Osborne, R
    Teklehaimanot, S
    Gill, G
    Liu, X
    LARYNGOSCOPE, 2003, 113 (03) : 393 - 400
  • [22] Role of miRNA in head and neck squamous cell carcinoma
    Masood, Yaghma
    Kqueen, Cheah Yoke
    Rajadurai, Pathmanathan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (02) : 183 - 197
  • [23] Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
    Llop, Sandra
    Plana, Maria
    Tous, Sara
    Ferrando-Diez, Angelica
    Brenes, Jesus
    Juarez, Marc
    Vidales, Zara
    Vilajosana, Esther
    Linares, Isabel
    Arribas, Lorena
    Duch, Maria
    Fulla, Marta
    Brunet, Aina
    Lozano, Alicia
    Cirauqui, Beatriz
    Mesia, Ricard
    Oliva, Marc
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [24] Role of cytokines in head and neck squamous cell carcinoma
    Pries, Ralph
    Nitsch, Stefan
    Wollenberg, Barbara
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (09) : 1195 - 1203
  • [25] Mechanism of Astrin in head and neck squamous cell carcinoma
    Wang, Jian
    Liu, Changjian
    Wei, Minghui
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (07) : 141 - 147
  • [26] Long-Noncoding RNA MANCR is Associated With Head and Neck Squamous Cell Carcinoma Malignant Development and Immune Infiltration
    Tang, Jianfei
    Bao, Mingyan
    Chen, Juan
    Bin, Xin
    Xu, Xinghuanyu
    Fang, Xiaodan
    Tang, Zhangui
    FRONTIERS IN GENETICS, 2022, 13
  • [27] Immune-related genes have prognostic significance in head and neck squamous cell carcinoma
    Yang, Jingrun
    Xie, Kuixia
    Li, Chengxin
    LIFE SCIENCES, 2020, 256
  • [28] Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma
    Young, M. Rita I.
    Neville, Brad W.
    Chi, Angela C.
    Lathers, Deane M. R.
    Gillespie, M. Boyd
    Day, Terry A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (07) : 1077 - 1086
  • [29] Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma
    M. Rita I. Young
    Brad W. Neville
    Angela C. Chi
    Deane M. R. Lathers
    M. Boyd Gillespie
    Terry A. Day
    Cancer Immunology, Immunotherapy, 2007, 56
  • [30] High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression
    Rodrigues-Junior, Dorival Mendes
    Tan, Soon Sim
    Lim, Sai Kiang
    Viana, Luciano de Souza
    Carvalho, Andre Lopes
    Vettore, Andre Luiz
    Iyer, N. Gopalakrishna
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (05): : 1199 - 1205